Civica Rx, a not-for-profit drug manufacturer founded by seven US health systems and three philanthropic organisations, increased supply security and lowered cost on aggregate for 20 drug products, according to the first empirical evidence of Civica's impact published in the journal NEJM Catalyst. "Results show that Civica was able to improve generic drug access above the wholesaler model," says the article in NEJM Catalyst, a publication that is part of the New England Journal of Medicine family.

https://www.miragenews.com/new-model-increases-generic-drug-supply-reduces-1089574/

#miragenews